Navigation Links
The John Theurer Cancer Center to host Seventh Annual Neuro-Oncology Symposium
Date:5/9/2011

HACKENSACK, N.J. (May 9, 2011) The John Theurer Cancer Center at Hackensack University Medical Center will host the Seventh Annual Neuro-Oncology Symposium on Friday, May 20 from 7:30am - 1:00pm. This continuing medical education (CME) conference will present the latest neuro-oncology trends by leaders in the field.

"For the seventh consecutive year, we are able to bring together leaders in neuro-oncology to provide insights on the latest advancements in the neuro-oncology field," said Viswanathan Rajaraman, M.D., Co-Chief of Neuro-Oncology at the John Theurer Cancer Center. "We are proud to bring together a group of highly esteemed oncologists to our new comprehensive cancer center to discuss the latest trends in our field."

Topics to be discussed at the Seventh Annual Neuro-Oncology Symposium: Controversies in Neuro-Oncology and Para Neoplastic Syndromes Affecting the CNS include controversies in radiosurgery and whole brain radiotherapy in metastatic brain tumors, management of para neoplastic syndrome, management of low grade gliomas, and identifying pitfalls in neuro-oncology imaging.

"The John Theurer Cancer Center is committed to helping our staff and the tri-state area neuro-oncology medical community stay up-to -date with the latest medical advancements through educational programs," said Mark Pascal, M.D., Co- Chief, Neuro-Oncology, John Theurer Cancer Center.

The program will feature neuro-oncology experts from world-renowned institutions such as Memorial Sloan-Kettering Cancer Center, Roswell Park Cancer Institute and University of Virginia Health System. Featured speakers include:

  • Jerome Posner, M.D., Memorial Sloan-Kettering Cancer Center, New York, NY
  • Dheerendra Prasad, M.D., Roswell Park Cancer Institute, Buffalo, NY
  • David Schiff, M.D., University of Virginia Health System, Charlottesville, VA
  • Andrei Holodny, M.D., Memorial Sloan-Kettering Cancer Center, New York, NY

"It is part of our mission at the John Theurer Cancer Center to promote research and innovation through education," said Andrew L. Pecora, M.D., C.P.E., F.A.C.P., Chief Innovations Officer and Professor and Vice President of Cancer Services at the John Theurer Cancer Center. "The Neuro-Oncology Symposium is just one example of the superior continuing medical education programs we offer throughout the year."

This program is open to the public, but is designed for neurologists, neurosurgeons, medical oncologists, radiation oncologists, internists, primary care physicians, neuropsychologists, other physicians and healthcare providers. Hackensack University Medical Center designates this educational activity for a maximum of 4.0 AMA PRA Category 1 Credit(s). The program will be held at the John Theurer Cancer Center at Hackensack University Medical Center, 92 Second Street, Hackensack, NJ in the #2 conference room.

This event is complimentary, however registration is required. To register, please contact Maryann V. Lederhilger at (551) 996-1162 or mlederhilger@humed.com. For updates and additional information, please visit jtcancercenter.org/neurooncologyCME.


'/>"/>

Contact: Jaymie DeGaetano
jaymie.degaetano@widmeyer.com
646-213-7243
John Theurer Cancer Center
Source:Eurekalert

Related medicine news :

1. John Theurer Cancer Center first in New Jersey to offer complete capabilities of Provenge
2. The MMRF and John Theurer Cancer Center to host patient symposium
3. John Theurer Cancer Center orthopedic oncologist shares new limb sparing surgical techniques
4. John Theurer Cancer Center to host Eighth Annual Northern New Jersey Breast Cancer Conference
5. Oncology basic research director at John Theurer Cancer Center continues transplantation research
6. John Theurer Cancer Center presents studies on promising therapies for aggressive blood cancers
7. The John Theurer Cancer Center to unveil 40 presentations at the 52nd ASH Annual Meeting
8. John Theurer Cancer Center to present innovative research at 2 surgical meetings
9. John Theurer Cancer Center first cancer center in N.J. to acquire new radiotherapy system
10. John Theurer Cancer Center and LLS host panel discussion with leading hematologists
11. The John Theurer Cancer Center recognizes medical physics team for safety track record
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... "With 30 ... their specific project," said Christina Austin - CEO of Pixel Film Studios. , ... and all within Final Cut Pro X . Simply select a ProHand generator ...
(Date:6/25/2016)... Oklahoma (PRWEB) , ... June 25, 2016 , ... ... both athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures ... Oklahoma City area —Johnson is one of the first doctors to perform the ...
(Date:6/24/2016)... Angeles, CA (PRWEB) , ... June 24, 2016 , ... ... surgery procedures that most people are unfamiliar with. The article goes on to state ... procedures, but also many of these less common operations such as calf and cheek ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, ... at his family verbally and physically. , “When something upset him, he couldn’t control his ... it. He would throw rocks at my other children and say he was going to ...
(Date:6/24/2016)... Francisco, CA (PRWEB) , ... June 24, 2016 ... ... CitiDent, is now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive ... self-ligating Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Research and ... Global Market - Forecast to 2022" report to their ... treatment method for the patients with kidney failure, it replaces ... fluid from the patient,s blood and thus the treatment helps ... and chloride in balance. Increasing number of ...
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
(Date:6/23/2016)... Pa. , June 23, 2016 Bracket ... will launch its next generation clinical outcomes platform, Bracket eCOA ... Meeting held on June 26 – 30, 2016 in ... the first electronic Clinical Outcome Assessment product of its kind ... Booth #715. Bracket eCOA 6.0 is a flexible ...
Breaking Medicine Technology: